APA (7th ed.) Citation

A, Q., J, Y., I, E., GM, A., JA, J., MC, M., . . . LL, H. (2021). Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2). Annals of internal medicine, 174(12), W116. https://doi.org/10.7326/L21-0607

Chicago Style (17th ed.) Citation

A, Qaseem, Yost J, Etxeandia-Ikobaltzeta I, Abraham GM, Jokela JA, Miller MC, Forciea MA, and Humphrey LL. "Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)." Annals of Internal Medicine 174, no. 12 (2021): W116. https://doi.org/10.7326/L21-0607.

MLA (9th ed.) Citation

A, Qaseem, et al. "Update Alert 2: Should Remdesivir Be Used for the Treatment of Patients With COVID-19? Rapid, Living Practice Points From the American College of Physicians (Version 2)." Annals of Internal Medicine, vol. 174, no. 12, 2021, p. W116, https://doi.org/10.7326/L21-0607.